Comparison of platelet rich plasma and corticosteroids in the management of lateral epicondylitis: A meta-analysis of randomized controlled trials

Seven RCTs (515 patients) were included in this meta-analysis comparing local injection of platelet rich plasma (PRP) and local injection of corticosteroid for the treatment of lateral epicondylitis. Outcomes of interest included pain on a Visual Analog Scale (VAS), the Modified Mayo Performance Index, the Disability of the Arm, Shoulder and Hand (DASH) score, and the risk of adverse events. Outcomes were analyzed up to 6 months post-treatment. Results revealed significantly favourable VAS pain, Mayo, and DASH in the PRP group compared to the corticosteroid group at all time points. The risk of adverse events was not significantly different between the two groups.